Daily Briefing
Chatgpt transitioning to superapp; an AI-designed Covid vax; Pope Leo blesses Sagrada
44 Articles •
OpenAI Plans to Turn ChatGPT into a 'Superapp' Ahead of IPO
L 14%
Center 32%
Right 54%
The plan: OpenAI is overhauling ChatGPT in the coming weeks to emphasize coding tools through its Codex product and AI agents, redesigning the interface to steer its 900 million weekly users toward coding, image generation, and partner services like Canva and Booking.com.
Why it matters: The shift targets lucrative enterprise clients who already generate 40 percent of OpenAI's revenue, expected to reach 50 percent by year-end, and comes as the company prepares for a potential IPO while competing intensely with rival Anthropic.
Blindspot: Low Coverage from Left Sources
84% of sources are Original Reporting
35 Articles •
Pope Leo XIV Blesses Sagrada Família's Final Tower
Left 45%
Center 40%
R 15%
What's happening: Pope Leo XIV will celebrate mass at Barcelona's Sagrada Família on June 10 to bless the recently completed 566-foot Jesus Christ tower, marking the centenary of architect Antoni Gaudí's death. The tower, finished in February and topped with a luminous white cross, makes the basilica the world's tallest church after 144 years of construction.
Why it matters: The blessing marks a symbolic completion of one of Spain's most visited monuments, drawing nearly 5 million visitors in 2025 alone. The event also advances Gaudí's sainthood cause after the Vatican declared him 'venerable' last year, though interior work will continue through the 2030s.
77% of sources are Original Reporting
41 Articles •
Study Links Europeans' Aversion to Eating Insects to Ancient Genomic Shifts
L 14%
Center 54%
Right 32%
The findings: Researchers analyzed dental plaque from 745 ancient humans, 18 Neanderthals, and 96 great apes spanning 45,000 to 1,500 years ago. Ancient Europeans showed minimal insect DNA in their teeth compared to Neanderthals and insect-eating apes, suggesting rare and likely accidental consumption over at least 9,000 years.
Why it matters: European populations have carried genetic variants linked to weaker chitin digestion for at least 9,000 years, suggesting ecological and evolutionary factors rather than just cultural preferences shaped this dietary pattern. Modern insect processing can reduce chitin content, potentially helping overcome this digestive barrier as insects gain attention as sustainable protein sources.
63% of sources are High Factuality
88 Articles •
Cambridge AI Vaccine Completes First Human Safety Trial
Left 37%
Center 41%
R 22%
What happened: University of Cambridge researchers and spin-out DIOSynVax completed the first human trial of an AI-designed coronavirus vaccine, testing 39 healthy volunteers aged 18-50 at facilities in Cambridge and Southampton. The vaccine triggered immune responses against SARS-CoV-2, SARS, and related bat coronaviruses, with a Phase II trial of over 200 participants planned next.
Why it matters: This AI-designed vaccine targets entire virus families rather than single strains, potentially eliminating the need for annual vaccine updates like current flu and COVID shots. If successful in larger trials, the needle-free platform could provide lasting protection against future coronavirus variants and pandemics before they emerge.
88% of sources are Original Reporting
Daily Briefing
Chatgpt transitioning to superapp; an AI-designed Covid vax; Pope Leo blesses Sagrada
44 Articles •
OpenAI Plans to Turn ChatGPT into a 'Superapp' Ahead of IPO
L 14%
Center 32%
Right 54%
The plan: OpenAI is overhauling ChatGPT in the coming weeks to emphasize coding tools through its Codex product and AI agents, redesigning the interface to steer its 900 million weekly users toward coding, image generation, and partner services like Canva and Booking.com.
Why it matters: The shift targets lucrative enterprise clients who already generate 40 percent of OpenAI's revenue, expected to reach 50 percent by year-end, and comes as the company prepares for a potential IPO while competing intensely with rival Anthropic.
Blindspot: Low Coverage from Left Sources
84% of sources are Original Reporting
35 Articles •
Pope Leo XIV Blesses Sagrada Família's Final Tower
Left 45%
Center 40%
R 15%
What's happening: Pope Leo XIV will celebrate mass at Barcelona's Sagrada Família on June 10 to bless the recently completed 566-foot Jesus Christ tower, marking the centenary of architect Antoni Gaudí's death. The tower, finished in February and topped with a luminous white cross, makes the basilica the world's tallest church after 144 years of construction.
Why it matters: The blessing marks a symbolic completion of one of Spain's most visited monuments, drawing nearly 5 million visitors in 2025 alone. The event also advances Gaudí's sainthood cause after the Vatican declared him 'venerable' last year, though interior work will continue through the 2030s.
77% of sources are Original Reporting
41 Articles •
Study Links Europeans' Aversion to Eating Insects to Ancient Genomic Shifts
L 14%
Center 54%
Right 32%
The findings: Researchers analyzed dental plaque from 745 ancient humans, 18 Neanderthals, and 96 great apes spanning 45,000 to 1,500 years ago. Ancient Europeans showed minimal insect DNA in their teeth compared to Neanderthals and insect-eating apes, suggesting rare and likely accidental consumption over at least 9,000 years.
Why it matters: European populations have carried genetic variants linked to weaker chitin digestion for at least 9,000 years, suggesting ecological and evolutionary factors rather than just cultural preferences shaped this dietary pattern. Modern insect processing can reduce chitin content, potentially helping overcome this digestive barrier as insects gain attention as sustainable protein sources.
63% of sources are High Factuality
88 Articles •
Cambridge AI Vaccine Completes First Human Safety Trial
Left 37%
Center 41%
R 22%
What happened: University of Cambridge researchers and spin-out DIOSynVax completed the first human trial of an AI-designed coronavirus vaccine, testing 39 healthy volunteers aged 18-50 at facilities in Cambridge and Southampton. The vaccine triggered immune responses against SARS-CoV-2, SARS, and related bat coronaviruses, with a Phase II trial of over 200 participants planned next.
Why it matters: This AI-designed vaccine targets entire virus families rather than single strains, potentially eliminating the need for annual vaccine updates like current flu and COVID shots. If successful in larger trials, the needle-free platform could provide lasting protection against future coronavirus variants and pandemics before they emerge.
88% of sources are Original Reporting